Genome-wide Detection of Allelic Imbalance Using Human SNPs and High-density DNA Arrays (original) (raw)

  1. Rui Mei1,7,
  2. Patricia C. Galipeau2,
  3. Cynthia Prass3,
  4. Anthony Berno1,
  5. Ghassan Ghandour4,
  6. Nila Patil1,
  7. Roger K. Wolff3,
  8. Mark S. Chee5,
  9. Brian J. Reid2, and
  10. David J. Lockhart1,6
  11. 1Affymetrix, Inc., Santa Clara, California 95051 USA;2Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104 USA;3Mercator Genetics, Inc., Menlo Park, California 94025 USA

Abstract

Most human cancers are characterized by genomic instability, the accumulation of multiple genetic alterations and allelic imbalance throughout the genome. Loss of heterozygosity (LOH) is a common form of allelic imbalance and the detection of LOH has been used to identify genomic regions that harbor tumor suppressor genes and to characterize tumor stages and progression. Here we describe the use of high-density oligonucleotide arrays for genome-wide scans for LOH and allelic imbalance in human tumors. The arrays contain redundant sets of probes for 600 genetic loci that are distributed across all human chromosomes. The arrays were used to detect allelic imbalance in two types of human tumors, and a subset of the results was confirmed using conventional gel-based methods. We also tested the ability to study heterogeneous cell populations and found that allelic imbalance can be detected in the presence of a substantial background of normal cells. The detection of LOH and other chromosomal changes using large numbers of single nucleotide polymorphism (SNP) markers should enable identification of patterns of allelic imbalance with potential prognostic and diagnostic utility.

Footnotes